Skip to main content
Log in

High-yield production of the VP1 structural protein epitope from serotype O foot-and-mouth disease virus in Escherichia coli

  • Fermentation, Cell Culture and Bioengineering
  • Published:
Journal of Industrial Microbiology & Biotechnology

Abstract

For effective control of foot-and-mouth disease (FMD), the development of rapid diagnostic systems and vaccines are required against its etiological agent, FMD virus (FMDV). To accomplish this, efficient large-scale expression of the FMDV VP1 protein, with high solubility, needs to be optimized. We attempted to produce high levels of a serotype O FMDV VP1 epitope in Escherichia coli. We identified the subtype-independent serotype O FMDV VP1 epitope sequence and used it to construct a glutathione S-transferase (GST) fusion protein. For efficient production of the FMDV VP1 epitope fused to GST (VP1e–GST), four E. coli strains and three temperatures were examined. The conditions yielding the greatest level of VP1e–GST with highest solubility were achieved with E. coli BL21(DE3) at 25 °C. For high-level production, fed-batch cultures were conducted in 5-l bioreactors. When cells were induced at a high density and complex feeding solutions were supplied, approximately 11 g of VP1e–GST was obtained from a 2.9-l culture. Following purification, the VP1 epitope was used to immunize rabbits, and we confirmed that it induced an immune response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Burman A, Clark S, Abrescia NG, Fry EE, Stuart DI, Jackson T (2006) Specificity of the VP1 GH loop of Foot-and-Mouth Disease virus for alphav integrins. J Virol 80(19):9798–9810

    Article  PubMed  CAS  Google Scholar 

  2. Carrillo C, Tulman E, Delhon G, Lu Z, Carreno A, Vagnozzi A, Kutish G, Rock D (2005) Comparative genomic of foot-and-mouth disease virus. J Virol Methods 79:6487–6504

    Article  CAS  Google Scholar 

  3. Challa S, Barrette R, Rood D, Zinckgraf J, French R, Silbart L (2007) Non-toxic Pseudomonas aeruginosa exotoxin A expressing the FMDV VP1 G-H loop for mucosal vaccination of swine against foot and mouth disease virus. Vaccine 25(17):3328–3337

    Article  PubMed  CAS  Google Scholar 

  4. Chiarella P, Edelmann B, Fazio VM, Sawyer AM, de Marco A (2010) Antigenic features of protein carriers commonly used in immunisation trials. Biotechnol Lett 32(9):1215–1221

    Article  PubMed  CAS  Google Scholar 

  5. Corisdeo S, Wang B (2004) Functional expression and display of an antibody Fab fragment in Escherichia coli: study of vector designs and culture conditions. Protein Expr Purif 34(2):270–279

    Article  PubMed  CAS  Google Scholar 

  6. Crooks GE, Hon G, Chandonia JM, Brenner SE (2004) WebLogo: a sequence logo generator. Genome Res 14(6):1188–1190

    Article  PubMed  CAS  Google Scholar 

  7. Dechamma HJ, Ashok Kumar C, Nagarajan G, Suryanarayana VV (2008) Processing of multimer FMD virus VP1-2A protein expressed in E. coli into monomers. Indian J Exp Biol 46(11):760–763

    PubMed  CAS  Google Scholar 

  8. Domingo E, Pariente N, Airaksinen A, Gonzalez-Lopez C, Sierra S, Herrera M, Grande-Perez A, Lowenstein PR, Manrubia SC, Lazaro E, Escarmis C (2005) Foot-and-mouth disease virus evolution: exploring pathways towards virus extinction. Curr Top Microbiol Immunol 288:149–173

    Article  PubMed  CAS  Google Scholar 

  9. Fowler VL, Bashiruddin JB, Maree FF, Mutowembwa P, Bankowski B, Gibson D, Cox S, Knowles N, Barnett PV (2011) Foot-and-mouth disease marker vaccine: cattle protection with a partial VP1 G-H loop deleted virus antigen. Vaccine 29(46):8405–8411

    Article  PubMed  CAS  Google Scholar 

  10. Fowler VL, Knowles NJ, Paton DJ, Barnett PV (2010) Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion. Vaccine 28(19):3428–3434

    Article  PubMed  CAS  Google Scholar 

  11. Gao SD, Du JZ, Chang HY, Cong GZ, Shao JJ, Lin T, Song S, Xie QG (2010) B cell epitopes within VP1 of type O foot-and-mouth disease virus for detection of viral antibodies. Virol Sin 25(1):18–26

    Article  PubMed  CAS  Google Scholar 

  12. Grubman MJ, Baxt B (2004) Foot-and-mouth disease. Clin Microbiol Rev 17(2):465–493

    Article  PubMed  CAS  Google Scholar 

  13. Hui RK, Leung FC (2012) Evolutionary trend of foot-and-mouth disease virus in Hong Kong. Vet Microbiol 159(1–2):221–229

    Article  PubMed  Google Scholar 

  14. Jackson T, King A, Stuart D, Fry E (2003) Structure and receptor binding. Virus Res 91:33–46

    Article  PubMed  CAS  Google Scholar 

  15. Jang SH, Lee CH, Kim YS, Jeong KJ (2011) High-level production of a kringle domain variant by high-cell-density cultivation of Escherichia coli. Appl Microbiol Biotechnol 92(2):327–336

    Article  PubMed  CAS  Google Scholar 

  16. Jeong KJ, Choi JH, Yoo WM, Keum KC, Yoo NC, Lee SY, Sung MH (2004) Constitutive production of human leptin by fed-batch culture of recombinant rpoS- Escherichia coli. Protein Expr Purif 36(1):150–156

    Article  PubMed  CAS  Google Scholar 

  17. Jeong KJ, Lee SY (1999) High-level production of human leptin by fed-batch cultivation of recombinant Escherichia coli and its purification. Appl Environ Microbiol 65(7):3027–3032

    PubMed  CAS  Google Scholar 

  18. Jeong KJ, Rani M (2011) High-level production of a single chain antibody against anthrax toxin in Escherichia coli by high cell density cultivation. Bioprocess Biosyst Eng 34(7):811–817

    Article  PubMed  CAS  Google Scholar 

  19. Kim J, Kim S, Nguyen D, Li H, Kim S, Seo Y, Yang J, Chung I, Kim D, Kim C (2009) Production of β-carotene by recombinant Escherichia coli with engineered whole mevalonate pathway in batch and bed-batch cultures. Biotechnol Bioprocess Eng 5:559–564

    Article  Google Scholar 

  20. Li Y, Sun M, Liu J, Yang Z, Zhang Z, Shen G (2006) High expression of foot-and-mouth disease virus structural protein VP1 in tobacco chloroplasts. Plant Cell Rep 25(4):329–333

    Article  PubMed  CAS  Google Scholar 

  21. Liu X, Wang Y, Zhang Y, Fang T, Pan L, Lü J, Zhou P, Zhang Z, Xqi-wei C, Wang G, Wang J, Lou H, Jiang S (2011) Cloning, codon-optimized expression and homology modeling of structural protein VP1 from foot and mouth disease virus. Afr J Microbiol Res 5:486–495

    CAS  Google Scholar 

  22. OIE (2011) OIE: Terrestrial animal health code. http://www.oie.int/eng/A_FMD2012/docs/en_chapitre_1.8.5.pdf

  23. Pfaff E, Thiel HJ, Beck E, Strohmaier K, Schaller H (1988) Analysis of neutralizing epitopes on foot-and-mouth disease virus. J Virol 62(6):2033–2040

    PubMed  CAS  Google Scholar 

  24. Sambrook J, Russell D (2001) Molecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor Laboratory Press, New York

    Google Scholar 

  25. Samuel AR, Knowles NJ (2001) Foot-and-mouth disease type O viruses exhibit genetically and geographically distinct evolutionary lineages (topotypes). J Gen Virol 82(Pt 3):609–621

    PubMed  CAS  Google Scholar 

  26. Shi XJ, Wang B, Zhang C, Wang M (2006) Expressions of Bovine IFN-gamma and foot-and-mouth disease VP1 antigen in P. pastoris and their effects on mouse immune response to FMD antigens. Vaccine 24(1):82–89

    Article  PubMed  CAS  Google Scholar 

  27. Sobrino F, Saiz M, Jimenez-Clavero MA, Nunez JI, Rosas MF, Baranowski E, Ley V (2001) Foot-and-mouth disease virus: a long known virus, but a current threat. Vet Res 32(1):1–30

    Article  PubMed  CAS  Google Scholar 

  28. Strohmaier K, Franze R, Adam KH (1982) Location and characterization of the antigenic portion of the FMDV immunizing protein. J Gen Virol 59(Pt 2):295–306

    Article  PubMed  CAS  Google Scholar 

  29. Subramaniam S, Sanyal A, Mohapatra JK, Hemadri D, Pattnaik B (2011) Comparative complete genome analysis of Indian type A foot-and-mouth disease virus field isolates. Virus Genes 43(2):224–233

    Article  PubMed  CAS  Google Scholar 

  30. van Lierop MJ, Wagenaar JP, van Noort JM, Hensen EJ (1995) Sequences derived from the highly antigenic VP1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus. J Virol 69(7):4511–4514

    PubMed  Google Scholar 

  31. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ (2009) Jalview Version 2–a multiple sequence alignment editor and analysis workbench. Bioinformatics 25(9):1189–1191

    Article  PubMed  CAS  Google Scholar 

  32. Wong HT, Cheng SC, Chan EW, Sheng ZT, Yan WY, Zheng ZX, Xie Y (2000) Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection. Virology 278(1):27–35

    Article  PubMed  CAS  Google Scholar 

  33. Zhang ZW, Zhang YG, Wang YL, Pan L, Fang YZ, Jiang ST, Lu JL, Zhou P (2010) Screening and identification of B cell epitopes of structural proteins of foot-and-mouth disease virus serotype Asia1. Vet Microbiol 140(1–2):25–33

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 20120005476).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ki Jun Jeong.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 212 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jung, JG., Lee, Y.J., Velmurugan, N. et al. High-yield production of the VP1 structural protein epitope from serotype O foot-and-mouth disease virus in Escherichia coli . J Ind Microbiol Biotechnol 40, 705–713 (2013). https://doi.org/10.1007/s10295-013-1273-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10295-013-1273-7

Keywords

Navigation